Actualités Takeda Pharmaceutical Co Ltd (PK) - TKPHF | Actions OTCMarkets

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Specialized Disclosure Report (sd)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM SDSpecialized Disclosure ReportTakeda Yakuhin KogyoKabushiki...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Report of Foreign Private IssuerPursuant to...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Amended Statement of Ownership (sc 13g/a)

jp3463000004_020723.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Table of ContentsFORM 6-K________________________________________U.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Report of Foreign Private IssuerPursuant to...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Takeda Pharmaceutical Co Ltd (PK) (TKPHF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

TKPHF Actualités

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Specialized Disclosure Report (sd)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Takeda Pharmaceutical Co Ltd (PK) (TKPHF) Actualités

Takeda Pharmaceutical Co Ltd (PK) (TKPHF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

TKPHF Actualités

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Specialized Disclosure Report (sd)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Ownership (sc 13g/a)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités